| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c0ed04d51028a24a01ddb5b8181b43b0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4e1ab0dd6c1ac12250f5fbb4ca0b6004
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cee6582ce9b81b27fba11f4a5d7fb8e6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ec6e3b3b68724d2499c8aaf6b5344bb6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9388e47347a073b476cf61f92a50c962
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4fc2165a42c3c07213a22cb9da8b2c93 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4184
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D235-08 |
| filingDate |
2009-11-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7660827e2638768e04ae0e7540ed1037
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aa9f008d261e1af8a415172c37c40af4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4479fb5f64fe6c2af0ed11bb44ef11d2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8e61e2876417be487171cdf134f8dc9d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_84c32a56ad7419e123b04a4d9a4f3803 |
| publicationDate |
2010-10-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2010116380-A2 |
| titleOfInvention |
A one pot process for preparing 2-butyl-3-[[2'-(1h-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1,3-diazaspiro [4, 4] non-1-en-4-one (irbesartan) |
| abstract |
A one pot process for the synthesis of Irbesartan comprising reacting 2-n-Butyl-1, 3-Diazaspiro [4, 4] Non -1-en-4-one (Formula III) and Bromomethyl Cyanobiphenyl (Formula IV) in the presence of base and water with the optional use of PTC to give formula II from which Irbesartan is obtained by reacting with sodium azide and triethylamine hydrochloride in the presence of a non polar solvent. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106083826-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108840860-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102807564-A |
| priorityDate |
2009-04-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |